![Who wants to be a billionaire? Not Actelion's founder and CEO, if it means selling out | Fierce Pharma Who wants to be a billionaire? Not Actelion's founder and CEO, if it means selling out | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/2016-11/Actelion.jpg?VersionId=5mO2CxGgAF5apNphVaag9lav1N4hNHqm)
Who wants to be a billionaire? Not Actelion's founder and CEO, if it means selling out | Fierce Pharma
![Swiss biotech Actelion CEO Jean-Paul Clozel endorses independence not acquisition - CEOWORLD magazine Swiss biotech Actelion CEO Jean-Paul Clozel endorses independence not acquisition - CEOWORLD magazine](https://ceoworld.biz/wp-content/uploads/2011/01/Jean-Paul-Clozel-Actelion.jpg)
Swiss biotech Actelion CEO Jean-Paul Clozel endorses independence not acquisition - CEOWORLD magazine
![Actelion spinout Idorsia hits goals in insomnia phase 2, sparking stock rise and talk of partnering up for pivotal trial | Fierce Biotech Actelion spinout Idorsia hits goals in insomnia phase 2, sparking stock rise and talk of partnering up for pivotal trial | Fierce Biotech](https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/2017-07/jean-paul-clozel.jpg?VersionId=XgbOevldywLeshp5Jmr7FuRH1aT38Vu4)
Actelion spinout Idorsia hits goals in insomnia phase 2, sparking stock rise and talk of partnering up for pivotal trial | Fierce Biotech
![Johnson & Johnson Chief Scientific Officer Pharmaceuticals Paul Stoffels (L) and Actelion CEO and founder Jean-Paul Clozel attend a news conference at Actelion headquarters in Allschwil, Switzerland January 26, 2017. REUTERS/Arnd Wiegmann Johnson & Johnson Chief Scientific Officer Pharmaceuticals Paul Stoffels (L) and Actelion CEO and founder Jean-Paul Clozel attend a news conference at Actelion headquarters in Allschwil, Switzerland January 26, 2017. REUTERS/Arnd Wiegmann](https://c8.alamy.com/comp/2CK5F4T/johnson-johnson-chief-scientific-officer-pharmaceuticals-paul-stoffels-l-and-actelion-ceo-and-founder-jean-paul-clozel-attend-a-news-conference-at-actelion-headquarters-in-allschwil-switzerland-january-26-2017-reutersarnd-wiegmann-2CK5F4T.jpg)